glp-1 shortage news today 2025 Pipeline Update: November - Prime Therapeutics GLP-1 Agonists Weight Loss Drugs
Description
We defined somatic comorbidity as having type 1 and 2 diabetes (ICD-10: E10, E11, E14), obesity (ICD-10: E66), heart disease (ICD-10: I20-I25), stroke (ICD-10: I61, I63, I64, G45) within 10 years prior to index date

How It Works: L-cells integrate signals from multiple nutrient sensors simultaneously

If you are a US patient looking for an affordable, physician-supervised path to GLP-1 therapy, FormBlends is one option to compare for compounded semaglutide and tirzepatide

This is important as metabolism rates such as total daily energy expenditure are greatly increased in children compared to adults [92]